File: b-be-11-bvw2-fiche-dinformation-destinee-au-public.pdfTrial reference: Clinical Study BNIT-PRV-301 - A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Prostate CancerDoc type: Information for the public
